English
Home > Products > CAS:595-33-5

China CAS:595-33-5 Manufacturer

Our growth depends to the superior products ,great talents and repeatedly strengthened technology forces for CAS:595-33-5, Our firm quickly grew in size and reputation because of its absolute dedication to superior quality manufacturing, substantial price of solutions and fantastic customer services.
CAS:595-33-5, Our company insists on the principle of "Quality First, Sustainable Development", and takes "Honest Business, Mutual Benefits" as our developable goal. All members sincerely thank all old and new customers' support. We'll keep working hard and offering you the highest-quality goods and service.

Related Products

Hot Products

  • Gestodene

    Gestodene

    Gestodene has CP and EP specification. DMF, GMP available.

    CAS:60282-87-3

  • Estradiol Valerate

    Estradiol Valerate

    Estradiol Valerate has CP specification. DMF approved.

    CAS:979-32-8

  • Revefenacin

    Revefenacin

    Revefenacin has In-house specification. DMF approved.

    CAS:864750-70-9

  • Mifepristone Capsules

    Mifepristone Capsules

    Mifepristone Capsules Specifications：10mg*1
    Indications：Emergency Contraceptive
  • Luliconazole

    Luliconazole

    Luliconazole has In-house specification, DMF approved.

    CAS:187164-19-8

  • Estrone

    Estrone

    Estrone is a female sex hormone. The weakest type of estrogen, it’s typically higher after menopause. Like all estrogen, estrone supports female sexual development and function. Low or high estrone can cause symptoms such as irregular bleeding, fatigue or mood swings.

    CAS:53-16-7

  • Related Blog
  • Reviews

  • 2021 API Exhibition Wuhan

    October 2021
    API China is a well-established comprehensive pharmaceuticals and chemicals show in Chinese pharmaceutical industry. With more than 40 years’ experience in China, it has been a well-known celebration for all parties involved in Chinese Pharmaceutical market.

  • 2022 API Exhibition Qingdao

    August 2022
    Founded by China National Medical Control Bureau (the predecessor of NPMA) in 1968.
    Gathering 97% of Top 100 Chinese pharmaceutical enterprises.
    99% manufactures meets the requirements of GMP.
    Supported by numerous powerful associations in China: CCFDIE, CPIA, CBPIA, CATCM, CNMA, CNPPA, etc.

  • 2023 See us at DCAT Week, CPHI and API exhibition!

  • What Are Chemical Intermediates and How Are They Used in Pharmaceutical Manufacturing

    At Humanwell, our two decades of experience are dedicated to mastering these very compounds. We understand that the purity, stability, and reliability of every Intermediates Category directly determine the safety, efficacy, and scalability of the final drug. This blog will delve into the indispensable role these molecules play and how Humanwell ensures your manufacturing process is built on a foundation of excellence.

  • How Can APIs Category Selection Improve Pharmaceutical Sourcing Confidence?

    Choosing the right APIs Category is not just a catalog task. It directly affects sourcing speed, regulatory preparation, technical communication, batch consistency, and long-term supply confidence.

  • Meet Us at CPHI Japan 2026 – Booth 2K32

    We will attend CPHI Japan 2026 at Tokyo Big Sight from April 21 to 23, with booth 2K32.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept